catechin has been researched along with Nasal Polyps in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, JS; Hong, SM; Kang, JS; Kim, TH; Lee, HM; Lee, SH; Park, IH | 1 |
| Hsiao, TY; Kok, SH; Lin, SK; Liu, CM; Shun, CT; Wang, CC | 1 |
2 other study(ies) available for catechin and Nasal Polyps
| Article | Year |
|---|---|
Epigallocatechin-3-gallate inhibits collagen production of nasal polyp-derived fibroblasts.
Topics: Actins; Adult; Antioxidants; Catechin; Cell Differentiation; Cells, Cultured; Collagen Type I; Extracellular Matrix; Female; Fibroblasts; Humans; Male; Myofibroblasts; Nasal Polyps; Reactive Oxygen Species; Transforming Growth Factor beta1 | 2014 |
Hypoxia-stimulated vascular endothelial growth factor production in human nasal polyp fibroblasts: effect of epigallocatechin-3-gallate on hypoxia-inducible factor-1 alpha synthesis.
Topics: Antioxidants; Camellia sinensis; Catechin; Cell Hypoxia; Cells, Cultured; Cobalt; Fibroblasts; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Nasal Polyps; Neovascularization, Pathologic; Plant Extracts; Vascular Endothelial Growth Factor A | 2008 |